1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size 2015-2025
2.1.2 Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Region
2.2 Preimplantation Genetic Diagnosis (PGD) Segment by Type
2.2.1 Chromosomal Abnormalities
2.2.2 Chromosomal Abnormalities
2.2.3 X-linked Diseases
2.2.4 Aneuploidy
2.2.5 Single Gene Disorders
2.2.6 Others
2.3 Preimplantation Genetic Diagnosis (PGD) Market Size by Type
2.3.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2015-2020)
2.3.2 Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (2015-2020)
2.4 Preimplantation Genetic Diagnosis (PGD) Segment by Application
2.4.1 Maternity Centers & Fertility Clinics
2.4.2 Hospitals, Diagnostic Labs, and Service Providers
2.4.3 Research Laboratories & Academic Institutes
2.5 Preimplantation Genetic Diagnosis (PGD) Market Size by Application
2.5.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2015-2020)
2.5.2 Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Application (2015-2020)
3 Global Preimplantation Genetic Diagnosis (PGD) by Players
3.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Players
3.1.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size by Players (2018-2020)
3.1.2 Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Players (2018-2020)
3.2 Global Preimplantation Genetic Diagnosis (PGD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Preimplantation Genetic Diagnosis (PGD) by Regions
4.1 Preimplantation Genetic Diagnosis (PGD) Market Size by Regions
4.2 Americas Preimplantation Genetic Diagnosis (PGD) Market Size Growth
4.3 APAC Preimplantation Genetic Diagnosis (PGD) Market Size Growth
4.4 Europe Preimplantation Genetic Diagnosis (PGD) Market Size Growth
4.5 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Growth
5 Americas
5.1 Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Countries
5.2 Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Type
5.3 Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Regions
6.2 APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Type
6.3 APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Preimplantation Genetic Diagnosis (PGD) by Countries
7.2 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type
7.3 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) by Countries
8.2 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type
8.3 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast (2021-2025)
10.2 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Regions
10.2.1 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Type
10.8 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Application
11 Key Players Analysis
11.1 Illumina
11.1.1 Company Details
11.1.2 Preimplantation Genetic Diagnosis (PGD) Product Offered
11.1.3 Illumina Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Illumina News
11.2 Yikon Genomics
11.2.1 Company Details
11.2.2 Preimplantation Genetic Diagnosis (PGD) Product Offered
11.2.3 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Yikon Genomics News
11.3 Thermo Fisher
11.3.1 Company Details
11.3.2 Preimplantation Genetic Diagnosis (PGD) Product Offered
11.3.3 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Thermo Fisher News
11.4 PerkinElmer
11.4.1 Company Details
11.4.2 Preimplantation Genetic Diagnosis (PGD) Product Offered
11.4.3 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 PerkinElmer News
11.5 Coopersurgical
11.5.1 Company Details
11.5.2 Preimplantation Genetic Diagnosis (PGD) Product Offered
11.5.3 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Coopersurgical News
11.6 Agilent Technologies
11.6.1 Company Details
11.6.2 Preimplantation Genetic Diagnosis (PGD) Product Offered
11.6.3 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Agilent Technologies News
11.7 Takara Bio
11.7.1 Company Details
11.7.2 Preimplantation Genetic Diagnosis (PGD) Product Offered
11.7.3 Takara Bio Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Takara Bio News
11.8 Abbott Laboratories
11.8.1 Company Details
11.8.2 Preimplantation Genetic Diagnosis (PGD) Product Offered
11.8.3 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Abbott Laboratories News
11.9 Oxford Gene Technology
11.9.1 Company Details
11.9.2 Preimplantation Genetic Diagnosis (PGD) Product Offered
11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Oxford Gene Technology News
11.10 Natera
11.10.1 Company Details
11.10.2 Preimplantation Genetic Diagnosis (PGD) Product Offered
11.10.3 Natera Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Natera News
11.11 Genea Limited
11.12 Quest Diagnostics
11.13 Bioarray
11.14 Progenesis
11.15 Invicta Genetics
11.16 Invitae
11.17 Combimatrix
11.18 Beijing Genomics Institute
12 Research Findings and Conclusion
...【免責事項】
https://www.globalresearch.jp/disclaimer